Tag: genomics
-
University, Company Employ AI for Anti-Aging Drugs
The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging.
-
Gene Editing, Therapy Company Gains $83.5M in Venture Funds
A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round.
-
Engineered Viruses Studied to Improve Plant Traits.
A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought.
-
The Three Most Revolutionary Emerging Sciences
Advanced technology has created new areas of study, so here are the top three.
-
RNA Vaccine for Rabies Found Safe, Generates Antibodies
A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies.
-
Start-Up Building Mobile Apps Combining DNA, Lifestyle
A new enterprise in California is creating smartphone apps that provide lifestyle advice based on DNA analysis and activity tracking.
-
FDA Grants Priority Review for Gene Therapy
A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.
-
Start-Up Applying Artificial Intelligence to New Drug Uses
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs.
-
Nanotech Treatment Studied for Brain Tumors
Medical researchers and engineers designed and tested in mice a way to deliver gene-silencing therapies in nanoscale particles to treat glioblastoma, an aggressive form of brain cancer.